Reimagining approaches to beating NCDs and liver cancer

Innovative approaches and new thinking are needed to turn the tide on noncommunicable diseases (NCDs), including cancer.

Liver cancer claims almost a million lives each year. Chronic viral hepatitis is its leading cause. As recognised in the political declaration of the fourth UN High-Level Meeting (HLM) on NCDs, diagnosis and treatment for hepatitis B and C, as well as vaccination for hepatitis B, can prevent new cases, increase early diagnosis and improve survival rates.

This unique interactive session brings together stakeholders from across the political and global health landscape to explore how to accelerate country-level action to scale up person-centred liver cancer prevention and NCD control through hepatitis testing, treatment and vaccination.

Speakers will discuss how the ‘Patient Charter to Improve Care for Hepatocellular Carcinoma’ and the World Hepatitis Alliance’s recent white paper, ‘Beating cancer through hepatitis elimination – working together to reduce NCDs’ can drive change. The NCD, cancer, hepatitis and universal health coverage (UHC) communities must come together to transform the response and save lives.

This will be a hybrid event, for both in-person and online attendance.

Supported by ASTRAZENECA.